Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "gravitate-helen",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips"
]
},
"identifier" : {
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "helen-ips-1"
},
"type" : "document",
"timestamp" : "2021-04-18T09:22:00+02:00",
"entry" : [
{
"fullUrl" : "https://myserver.org/Composition/5702fd1d-dd26-402e-a7c0-7629a5d9bba1",
"resource" : {
"resourceType" : "Composition",
"id" : "gravitate-helen",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Composition_gravitate-helen\"> </a><p><b>Generated Narrative: Composition</b><a name=\"gravitate-helen\"> </a><a name=\"hcgravitate-helen\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceComposition "gravitate-helen" </p></div><p><b>status</b>: final</p><p><b>type</b>: Patient summary Document <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#60591-5)</span></p><p><b>date</b>: 2018-07-10 15:22:00+0200</p><p><b>author</b>: See on this page: Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266: Dr. Anna Karlsson</p><p><b>title</b>: Patient Summary (Helen Gravitate)</p><p><b>confidentiality</b>: N</p></div>"
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "60591-5",
"display" : "Patient summary Document"
}
]
},
"subject" : {
"reference" : "Patient/be61951b-44fc-4853-8822-f9d398193c50",
"display" : "Helen Gravitate"
},
"date" : "2018-07-10T15:22:00+02:00",
"author" : [
{
"reference" : "Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266",
"display" : "Dr. Anna Karlsson"
}
],
"title" : "Patient Summary (Helen Gravitate)",
"confidentiality" : "N",
"section" : [
{
"title" : "Allergies and Intolerances",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "48765-2",
"display" : "Allergies and adverse reactions Document"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Hay fever (pollen)</li></ul></div>"
},
"entry" : [
{
"reference" : "AllergyIntolerance/cb6e84fa-4302-4569-ac1c-6b1b32507d16",
"display" : "Lactose Intolerance"
}
]
},
{
"title" : "Problem List",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11450-4",
"display" : "Problem list Reported"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Diabetes type 1</li></ul></div>"
},
"entry" : [
{
"reference" : "Condition/de06df6b-0967-4b01-822b-7cfeea970aa7",
"display" : "Diabetes type 1"
}
]
},
{
"title" : "Medication Summary",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "10160-0",
"display" : "Hx of Medication use"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Humalog Mix50 Insulin KwikPen, 3ml pre-fill</td><td>EU/1/96/007/035</td><td>insulin lispro (GFX7QIS1II)</td><td>insulin lispro</td><td>A10AD04</td><td>100 U/ml</td><td>Suspension for injection</td><td>Subcutaneous use</td></tr><tr><td>Monuril 3 g granules for oral solution</td><td>PL31654/0006</td><td>FOSFOMYCIN (2N81MY12TE)</td><td>fosfomycin</td><td>J01XX01</td><td>3 g (as trometamol: 5.631g/sachet)</td><td>Granules for oral solution</td><td>Oral use</td></tr></tbody></table></div>"
},
"entry" : [
{
"reference" : "MedicationStatement/18eb9898-dea7-4c5e-b097-e507e011747b",
"display" : "Humalog Mix50 Insulin KwikPen, 3ml pre-fill"
},
{
"reference" : "MedicationStatement/c90b943a-3d8e-4f14-b56d-5c5c208b2065",
"display" : "Monuril 3 g granules for oral solution"
}
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/Patient/be61951b-44fc-4853-8822-f9d398193c50",
"resource" : {
"resourceType" : "Patient",
"id" : "be61951b-44fc-4853-8822-f9d398193c50",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Helen Gravitate, Female, 75 years old (1946-05-05)</div>"
},
"extension" : [
{
"extension" : [
{
"url" : "code",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "GB",
"display" : "United Kingdom of Great Britain and Northern Ireland"
}
]
}
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
}
],
"identifier" : [
{
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "helen-1"
}
],
"active" : true,
"name" : [
{
"family" : "Gravitate",
"given" : [
"Helen"
]
}
],
"gender" : "female",
"birthDate" : "1946-05-05"
}
},
{
"fullUrl" : "https://myserver.org/Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266",
"resource" : {
"resourceType" : "Practitioner",
"id" : "45cd0bd4-f685-4117-a9f0-5c53fffb7266",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Dr. Anne Karlsson</div>"
},
"name" : [
{
"family" : "Karlsson",
"given" : [
"Anne"
],
"prefix" : [
"Dr."
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/AllergyIntolerance/cb6e84fa-4302-4569-ac1c-6b1b32507d16",
"resource" : {
"resourceType" : "AllergyIntolerance",
"id" : "cb6e84fa-4302-4569-ac1c-6b1b32507d16",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Lactose Intolerance</div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
"code" : "active"
}
]
},
"verificationStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
"code" : "confirmed"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "47703008",
"display" : "Lactose"
}
]
},
"patient" : {
"reference" : "Patient/be61951b-44fc-4853-8822-f9d398193c50",
"display" : "Helen Gravitate"
}
}
},
{
"fullUrl" : "https://myserver.org/Condition/de06df6b-0967-4b01-822b-7cfeea970aa7",
"resource" : {
"resourceType" : "Condition",
"id" : "de06df6b-0967-4b01-822b-7cfeea970aa7",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Diabetes mellitus type 1 (2015)</div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "46635009",
"display" : "Diabetes mellitus type 1"
}
],
"text" : "Diabetes type 1"
},
"subject" : {
"reference" : "Patient/be61951b-44fc-4853-8822-f9d398193c50",
"display" : "Helen Gravitate"
},
"onsetDateTime" : "2015",
"asserter" : {
"reference" : "Practitioner/45cd0bd4-f685-4117-a9f0-5c53fffb7266",
"display" : "Dr. Anna Karlsson"
}
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/18eb9898-dea7-4c5e-b097-e507e011747b",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "18eb9898-dea7-4c5e-b097-e507e011747b",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Humalog Mix50 Insulin KwikPen, 3ml pre-fill</td><td>EU/1/96/007/035</td><td>insulin lispro (GFX7QIS1II)</td><td>insulin lispro</td><td>A10AD04</td><td>100 U/ml</td><td>Suspension for injection</td><td>Subcutaneous use</td></tr></tbody></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/9d7be868-8264-4d94-ad04-ef04ecc92e50",
"display" : "Humalog Mix50 Insulin KwikPen, 3ml pre-fill"
},
"subject" : {
"reference" : "Patient/be61951b-44fc-4853-8822-f9d398193c50",
"display" : "Helen Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20066000",
"display" : "Subcutaneous use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/c90b943a-3d8e-4f14-b56d-5c5c208b2065",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "c90b943a-3d8e-4f14-b56d-5c5c208b2065",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Monuril 3 g granules for oral solution</td><td>PL31654/0006</td><td>FOSFOMYCIN (2N81MY12TE)</td><td>fosfomycin</td><td>J01XX01</td><td>3 g (as trometamol: 5.631g/sachet)</td><td>Granules for oral solution</td><td>Oral use</td></tr></tbody></table></div>"
},
"basedOn" : [
{
"reference" : "MedicationRequest/c872135e-f219-4f32-8fd6-7099009abf42"
}
],
"status" : "active",
"medicationReference" : {
"reference" : "Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3",
"display" : "Monuril 3g granules for oral solution"
},
"subject" : {
"reference" : "Patient/be61951b-44fc-4853-8822-f9d398193c50",
"display" : "Helen Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationRequest/c872135e-f219-4f32-8fd6-7099009abf42",
"resource" : {
"resourceType" : "MedicationRequest",
"id" : "c872135e-f219-4f32-8fd6-7099009abf42",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationRequest_c872135e-f219-4f32-8fd6-7099009abf42\"> </a><p><b>Generated Narrative: MedicationRequest</b><a name=\"c872135e-f219-4f32-8fd6-7099009abf42\"> </a><a name=\"hcc872135e-f219-4f32-8fd6-7099009abf42\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationRequest "c872135e-f219-4f32-8fd6-7099009abf42" </p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: See on this page: Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3: Monuril</p><p><b>subject</b>: See on this page: Patient/be61951b-44fc-4853-8822-f9d398193c50</p></div>"
},
"status" : "active",
"intent" : "order",
"medicationReference" : {
"reference" : "Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3",
"display" : "Monuril"
},
"subject" : {
"reference" : "Patient/be61951b-44fc-4853-8822-f9d398193c50"
}
}
},
{
"fullUrl" : "https://myserver.org/Medication/9d7be868-8264-4d94-ad04-ef04ecc92e50",
"resource" : {
"resourceType" : "Medication",
"id" : "9d7be868-8264-4d94-ad04-ef04ecc92e50",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_9d7be868-8264-4d94-ad04-ef04ecc92e50\"> </a><p><b>Generated Narrative: Medication</b><a name=\"9d7be868-8264-4d94-ad04-ef04ecc92e50\"> </a><a name=\"hc9d7be868-8264-4d94-ad04-ef04ecc92e50\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "9d7be868-8264-4d94-ad04-ef04ecc92e50" </p></div><p><b>code</b>: Humalog Mix50 KwikPen 100 U/ml 5 pre-filled pen <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#EU/1/96/007/035; phpid#0xF79CABF272B6A7EEF104DDDA44E82717 "Insulin Lispro 100 U/ml 5 pre-filled pen"; <a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#388454007 "Product containing insulin lispro (medicinal product)"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#A10AD04 "insulin lispro")</span></p><p><b>form</b>: Suspension for injection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#11202000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>insulin lispro <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#GFX7QIS1II)</span></td><td>100 units<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code U = 'U')</span>/1 ml<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code ml = 'ml')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "EU/1/96/007/035",
"display" : "Humalog Mix50 KwikPen 100 U/ml 5 pre-filled pen"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xF79CABF272B6A7EEF104DDDA44E82717",
"display" : "Insulin Lispro 100 U/ml 5 pre-filled pen"
},
{
"system" : "http://snomed.info/sct",
"code" : "388454007",
"display" : "Product containing insulin lispro (medicinal product)"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "A10AD04",
"display" : "insulin lispro"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "11202000",
"display" : "Suspension for injection"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "GFX7QIS1II",
"display" : "insulin lispro"
}
],
"text" : "insulin lispro"
},
"strength" : {
"numerator" : {
"value" : 100,
"unit" : "units",
"system" : "http://unitsofmeasure.org",
"code" : "U"
},
"denominator" : {
"value" : 1,
"unit" : "ml",
"system" : "http://unitsofmeasure.org",
"code" : "ml"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3",
"resource" : {
"resourceType" : "Medication",
"id" : "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3\"> </a><p><b>Generated Narrative: Medication</b><a name=\"fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3\"> </a><a name=\"hcfdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e3" </p></div><p><b>code</b>: Monuril <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#PL31654/0087; phpid#0xE857DA811B4A6F3BD57810C45D2EA1RF "Fosfomycin, 3g, Granules for oral solution"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#J01XX01 "fosfomycin")</span></p><p><b>form</b>: Granules for oral solution <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10112000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>FOSFOMYCIN TROMETAMOL <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#7FXW6U30GY "FOSFOMYCIN TROMETHAMINE")</span></td><td>5.631 g<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code g = 'g')</span>/1 Sachet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {sachet} = '{sachet}')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "PL31654/0087",
"display" : "Monuril"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xE857DA811B4A6F3BD57810C45D2EA1RF",
"display" : "Fosfomycin, 3g, Granules for oral solution"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "J01XX01",
"display" : "fosfomycin"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10112000",
"display" : "Granules for oral solution"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "7FXW6U30GY",
"display" : "FOSFOMYCIN TROMETHAMINE"
}
],
"text" : "FOSFOMYCIN TROMETAMOL"
},
"strength" : {
"numerator" : {
"value" : 5.631,
"unit" : "g",
"system" : "http://unitsofmeasure.org",
"code" : "g"
},
"denominator" : {
"value" : 1,
"unit" : "Sachet",
"system" : "http://unitsofmeasure.org",
"code" : "{sachet}"
}
}
}
]
}
}
]
}
IG © 2021+ . Package hl7.eu.fhir.gh-ips#0.1.0 based on FHIR 4.0.1. Generated 2024-05-14
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
